Back to top
more

Ingevity (NGVT)

(Delayed Data from NYSE)

$45.15 USD

45.15
145,843

+0.71 (1.60%)

Updated Jul 22, 2024 04:00 PM ET

After-Market: $45.14 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why Ingevity (NGVT) is a Strong Momentum Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wall Street Analysts Think Ingevity (NGVT) Could Surge 45%: Read This Before Placing a Bet

by Zacks Equity Research

The consensus price target hints at a 44.6% upside potential for Ingevity (NGVT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Should Value Investors Buy AdvanSix (ASIX) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Ingevity's (NGVT) Earnings and Sales Surpass Estimates in Q1

by Zacks Equity Research

Ingevity (NGVT) gains on actions to increase prices and strong end-market demand in Q1.

Ingevity (NGVT) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 45.95% and 11.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Highlights Daqo New Energy, Ingevity, AdvanSix and Hawkins

by Zacks Equity Research

Daqo New Energy, Ingevity, AdvanSix and Hawkins have been highlighted in this Industry Outlook article.

Is DAQO New Energy (DQ) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Anindya Barman headshot

4 Chemical Specialty Stocks to Escape Industry Challenges

by Anindya Barman

Soft automotive demand and input cost pressure dampen prospects for the Zacks Chemicals Specialty industry. DQ, NGVT, ASIX and HWKN are set to gain from self-help actions.

Ingevity (NGVT) is a Top-Ranked Growth Stock: Should You Buy?

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why You Should Add Ingevity (NGVT) Stock to Your Portfolio

by Zacks Equity Research

Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.

Ingevity (NGVT) Down 1.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Is Ingevity (NGVT) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Element Solutions (ESI) Soars 9.2%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Element Solutions (ESI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Is Ingevity (NGVT) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Wall Street Analysts Predict a 40% Upside in Ingevity (NGVT): Here's What You Should Know

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 39.7% in Ingevity (NGVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Ingevity's (NGVT) Q4 Earnings and Revenues Beat Estimate

by Zacks Equity Research

Ingevity's (NGVT) Q4 results benefit from higher volumes in the Performance Chemicals segment.

Ingevity (NGVT) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 9.86% and 15.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Livent (LTHM) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Livent (LTHM) delivered earnings and revenue surprises of 14.29% and 17.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Ingevity's (NGVT) Earnings and Sales Beat Estimates in Q3

by Zacks Equity Research

Ingevity's (NGVT) third-quarter results benefit from higher demand and price increases in its Performance Chemicals business.

Ingevity (NGVT) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 6.58% and 5.40%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Ingevity (NGVT) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingevity (NGVT) to Boost Monomer Capacity Due to Demand Surge

by Zacks Equity Research

Ingevity (NGVT) to boost caprolactone monomer production at its Warrington unit to more effectively cater to the rising demand in its engineered polymers portfolio.